Alpracad 0.25mg Tablet
By Alpracad
Rx
10 Tablet in a Strip

Composition
Alprazolam(0.25mg)

Manufacturer - Zydus Healthcare Limited
Zydus Tower, CTS No- 460/6 of Village Pahadi, Off I. B. Patel Road, Goregaon (East), Mumbai-400 063

Expires on or after
October, 2025

liver
Alpracad 0.25mg Tablet should be used carefully in individuals with liver disease. It may be necessary to adjust the dosage of Alpracad 0.25mg Tablet for patients with liver issues. It is advisable to consult with your doctor regarding the use of this medication if you have any liver-related concerns.

kidney
Alpracad 0.25mg Tablet is likely safe for use in kidney disease patients. Existing data indicates dose adjustment may not be necessary. Consult your doctor for guidance.

alcohol
It is not safe to drink alcohol while taking Alpracad 0.25mg Tablet.

driving
When taking Alpracad 0.25mg Tablet, be cautious as it may lower alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if these effects are experienced.

pregnancy
Alpracad 0.25mg Tablet is considered unsafe during pregnancy due to potential risk to the developing baby. Only use in life-threatening situations if benefits outweigh risks. Consult doctor before use.

breastfeeding
Alpracad 0.25mg Tablet may not be safe to use while breastfeeding as it can potentially pass into breastmilk and harm the baby.
Habit Forming | Yes |
Chemical Class | Benzodiazepines Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Benzodiazepines |
₹20.85
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024